Puma Biotechnology Inc reports results for the quarter ended in March - Earnings Summary

Puma Biotechnology

04/05/2023 22:03

* Puma Biotechnology Inc  PBYI.OQ  reported quarterly
adjusted
earnings of 3 cents​​ per share for the quarter ended in March.
The mean expectation of four analysts for the quarter was for a
loss of 7 cents per share.
    * Revenue rose 15.5% to $52.80 million from a year ago;
analysts
expected $49.63 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
3
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1,650% in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Puma Biotechnology Inc shares had fallen by 14.9% this
quarter and lost 37.8% so far this year.
    * The company reported quarterly net income of $1.4 million.
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $5.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 09:03 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.07          0.03           Beat
 Dec. 31 2022      0.05           -0.12          Missed
 Sep. 30 2022      -0.05          -0.01          Beat
 Jun. 30 2022      0.01           0.21           Beat